InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Vivaldi Coelho Rogerio, Chairman & CEO. Director active across 1 companies, notably Sigilon Therapeutics, Inc.. In total, 2 disclosures have been logged. The latest transaction was disclosed on 4 November 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
050,000 shares0
Common Stock
SEC:0001415889-21-005084·
050,000 shares0
Common Stock
SEC:0001415889-21-005084:0·
2 of 2 declarations
About Vivaldi Coelho Rogerio
Rogerio Vivaldi Coelho is the President and CEO of Sigilon Therapeutics, Inc. In this role, he oversees all operations of the company and is responsible for overall strategy. His leadership is essential for guiding the company's direction and achieving its growth objectives.
